Succimer chelation normalizes reactivity to reward omission and errors in lead-exposed rats

Neurotoxicology and Teratology

Volumn 29, Issue 2, 2007, Pages 188-202

  Beaudin, Stéphane A ^a   Stangle, Diane E ^a   Smith, Donald R ^b   Levitsky, David A ^a   Strupp, Barbara J ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arousal regulation; Behavior; Chelating agents; Chelation; Emotion regulation; Error monitoring; Lead exposure; Lead poisoning; Reward omission; Succimer

Indexed keywords

LEAD; SUCCIMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; ARTICLE; BEHAVIOR DISORDER; CHELATION; CHELATION THERAPY; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; EMOTIONALITY; FACTORIAL ANALYSIS; LATENT PERIOD; LEAD POISONING; NONHUMAN; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; RAT; REWARD; TASK PERFORMANCE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BODY WEIGHT; CHELATING AGENTS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEMALE; LEAD POISONING; OLFACTORY BULB; RATS; REWARD; SUCCIMER;

ANIMALIA; RATTUS;

EID: 33947122798     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2006.11.004     Document Type: Article

References (119)

1. Alber S.A., and Strupp B.J. An in-depth analysis of lead effects in a delayed spatial alternation task: assessment of mnemonic effects, side bias, and proactive interference. Neurotoxicol. Teratol. 18 (1996) 3-15
2. American Academy of Pediatrics and Committee on Environmental Health. Lead exposure in children: prevention, detection, and management. American Academy of Pediatrics Committee on Environmental Health. Pediatrics 116 (2005) 1036-1046
3. Aposhian H.V., and Aposhian M.M. Meso-2,3-dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 279-306
4. Aposhian H.V., Maiorino R.M., Dart R.C., and Perry D.F. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects. Clin. Pharmacol. Ther. 45 (1989) 520-526
5. Aposhian H.V., Maiorino R.M., Gonzalez-Ramirez D., Zuniga-Charles M., Xu Z., Hurlbut K.M., Junco-Munoz P., Dart R.C., and Aposhian M.M. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 97 (1995) 23-38
6. Barrett J., and Livesey P.J. Low level lead effects on activity under varying stress conditions in the developing rat. Pharmacol. Biochem. Behav. 22 (1985) 107-118
7. Beaudin S.A., Stangle D., and Strupp B.J. Lasting effects of early lead exposure on reactivity to errors, but not omission of reward. Neurotoxicol. Teratol. 23 (2001) 291-294
8. Bellinger D.C. Future directions for neurobehavioral studies of environmental neurotoxicants. Neurotoxicology 22 (2001) 645-656
9. Bellinger D., Leviton A., Allred E., and Rabinowitz M. Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ. Res. 66 (1994) 12-30
10. Bernard S.M., and McGeehin M.A. Prevalence of blood lead levels > or = 5 micro g/dl among US children 1 to 5 years of age and socioeconomic and demographic factors associated with blood of lead levels 5 to 10 micro g/d, Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics 112 (2003) 1308-1313
11. Berry Jr. W.D., Moriarty C.M., and Lau Y.S. Lead attenuation of episodic growth hormone secretion in male rats. Int. J. Toxicol. 21 (2002) 93-98
12. Brody D.J., Pirkle J.L., Kramer R.A., Flegal K.M., Matte T.D., Gunter E.W., and Paschal D.C. Blood lead levels in the US population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA 272 (1994) 277-283
13. Burns J.M., Baghurst P.A., Sawyer M.G., McMichael A.J., and Tong S.L. Lifetime low-level exposure to environmental lead and children's emotional and behavioral development at ages 11-13 years. The Port Pirie Cohort Study. Am. J. Epidemiol. 149 (1999) 740-749
14. Bush G., Luu P., and Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 4 (2000) 215-222
15. Byers R.K., and Lord E.E. Late effects of Pb poisoning on mental development. Am. J. Dis. Child. 66 (1943) 471-494
16. Canfield R.L., Henderson Jr. C.R., Cory-Slechta D.A., Cox C., Jusko T.A., and Lanphear B.P. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N. Engl. J. Med. 348 (2003) 1517-1526
17. Canfield R.L., Kreher D.A., Cornwell C., and Henderson Jr. C.R. Low-level lead exposure, executive functioning, and learning in early childhood. Neuropsychol. Dev. Cogn., Sect. C, Child. Neuropsychol. 9 (2003) 35-53
18. Centers for Disease Control and Prevention. Childhood Blood Lead Surveillance Program (1998), Centers for Disease Control and Prevention, Atlanta, GA
19. Centers for Disease Control and Prevention. Managing Elevated Blood Lead Levels Among Young Children: Recommendations From the Advisory Committee on Childhood Lead Poisoning Prevention (2002), Centers for Disease Control and Prevention, Atlanta, GA
20. Chiodo L.M., Jacobson S.W., and Jacobson J.L. Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol. Teratol. 26 (2004) 359-371
21. Chisholm J.J. The use of chelating agents in the treatment of acute and chronic lead intoxication in children. J. Pediatr. 73 (1968) 1-38
22. Chisholm Jr. J.J. BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children. J. Toxicol. Clin. Toxicol. 30 (1992) 493-504
23. Chisholm J.J., and Harrison H.E. The treatment of acute Pb encephalopathy in children. Pediatrics 19 (1957) 2-20
24. Cory-Slechta D.A. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy. J. Pharmacol. Exp. Ther. 246 (1988) 84-91
25. Cory-Slechta D.A., Virgolini M.B., Thiruchelvam M., Weston D.D., and Bauter M.R. Maternal stress modulates the effects of developmental lead exposure. Environ. Health Perspect. 112 (2004) 717-730
26. Cremin Jr. J.D., Luck M.L., Laughlin N.K., and Smith D.R. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure. Toxicol. Appl. Pharmacol. 161 (1999) 283-293
27. Daly H.B. Arousal of frustration following gradual reductions in reward magnitude in rats. J. Comp. Physiol. Psychol. 86 (1974) 1149-1155
28. Davidson R.J., Putnam K.M., and Larson C.L. Dysfunction in the neural circuitry of emotion regulation-a possible prelude to violence. Science 289 (2000) 591-594
29. Davis J.M., Otto D.A., Weil D.E., and Grant L.D. The comparative developmental neurotoxicity of lead in humans and animals. Neurotoxicol. Teratol. 12 (1990) 215-229
30. Davis S.F., Nation J.R., and Mayleben M.A. The effects of chronic lead exposure on reactivity to frustrative nonreward in rats. Toxicol. Lett. 66 (1993) 237-246
31. Dietrich K.N., Ris M.D., Succop P.A., Berger O.G., and Bornschein R.L. Early exposure to lead and juvenile delinquency. Neurotoxicol. Teratol. 23 (2001) 511-518
32. Dietrich K.N., Ware J.H., Salganik M., Radcliffe J., Rogan W.J., Rhoads G.G., Fay M.E., Davoli C.T., Denckla M.B., Bornschein R.L., Schwarz D., Dockery D.W., Adubato S., and Jones R.L. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics 114 (2004) 19-26
33. Driscoll J.W., and Stegner S.E. Behavioral effects of chronic lead ingestion on laboratory rats. Pharmacol. Biochem. Behav. 4 (1976) 411-417
34. Driscoll J.W., and Stegner S.E. Lead-produced changes in the relative rate of open field activity of laboratory rats. Pharmacol. Biochem. Behav. 8 (1978) 743-747
35. Driscoll L.L., Carroll J.C., Moon J., Crnic L.S., Levitsky D.A., and Strupp B.J. Impaired sustained attention and error-induced stereotypy in the aged Ts65Dn mouse: a mouse model of Down syndrome and Alzheimer's disease. Behav. Neurosci. 118 (2004) 1196-1205
36. Elliott R., Sahakian B.J., McKay A.P., Herrod J.J., Robbins T.W., and Paykel E.S. Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychol. Med. 26 (1996) 975-989
37. A.S. Ettinger, Chelation therapy for childhood lead poisoning: Does excretion equal efficacy? in: http://www.hsph.harvard.edu/Organizations/DDIL/chelation.htm (Ed.), 2005.
38. Ferguson S.A., and Bowman R.E. Effects of postnatal lead exposure on open field behavior in monkeys. Neurotoxicol. Teratol. 12 (1990) 91-97
39. Fergusson D.M., Horwood L.J., and Lynskey M.T. Early dentine lead levels and subsequent cognitive and behavioural development. J. Child Psychol. Psychiatry 34 (1993) 215-227
40. Ferguson S.A., Holson R.R., Gazzara R.A., and Siitonen P.H. Minimal behavioral effects from moderate postnatal lead treatment in rats. Neurotoxicol. Teratol. 20 (1998) 637-643
41. Fernandez-Duque D., Baird J.A., and Posner M.I. Executive attention and metacognitive regulation. Conscious. Cogn. 9 (2000) 288-307
42. Finkelstein Y., Markowitz M.E., and Rosen J.F. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res. Brain Res. Rev. 27 (1998) 168-176
43. Fournier L., Thomas G., Garnier R., Buisine A., Houze P., Pradier F., and Dally S. 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans. Med. Toxicol. Adverse Drug Exp. 3 (1988) 499-504
44. Friedman L.M., Furberg C.D., and Demets D.L. Fundamentals of Clinical Trials (1998), Springer-Verlag, New York
45. Garavan H., Morgan R.E., Levitsky D.A., Hermer-Vazquez L., and Strupp B.J. Enduring effects of early lead exposure: evidence for a specific deficit in associative ability. Neurotoxicol. Teratol. 22 (2000) 151-164
46. Gendle M.H., Strawderman M.S., Mactutus C.F., Booze R.M., Levitsky D.A., and Strupp B.J. Impaired sustained attention and altered reactivity to errors in an animal model of prenatal cocaine exposure. Brain Res. Dev. Brain Res. 147 (2003) 85-96
47. Gendle M.H., White T.L., Strawderman M., Mactutus C.F., Booze R.M., Levitsky D.A., and Strupp B.J. Enduring effects of prenatal cocaine exposure on selective attention and reactivity to errors: evidence from an animal model. Behav. Neurosci. 118 (2004) 290-297
48. Glotzer D.E., and Bauchner H. Management of childhood lead poisoning: a survey. Pediatrics 89 (1992) 614-618
49. Gong Z., and Evans H.L. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat. Toxicol. Appl. Pharmacol. 144 (1997) 205-214
50. Gordon R.A., Roberts G., Amin Z., Williams R.H., and Paloucek F.P. Aggressive approach in the treatment of acute lead encephalopathy with an extraordinarily high concentration of lead. Arch. Pediatr. Adolesc. Med. 152 (1998) 1100-1104
51. Goyer R.A., Cherian M.G., Jones M.M., and Reigart J.R. Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals. Environ. Health Perspect. 103 (1995) 1048-1052
52. Graziano J.H. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med. Toxicol. 1 (1986) 155-162
53. Graziano J.H., Cuccia D., and Friedheim E. The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning. J. Pharmacol. Exp. Ther. 207 (1978) 1051-1055
54. Graziano J.H., Leong J.K., and Friedheim E. 2,3-Dimercaptosuccinic acid: a new agent for the treatment of lead poisoning. J. Pharmacol. Exp. Ther. 206 (1978) 696-700
55. Graziano J.H., Siris E.S., LoIacono N., Silverberg S.J., and Turgeon L. 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication. Clin. Pharmacol. Ther. 37 (1985) 431-438
56. Graziano J.H., Lolacono N.J., and Meyer P. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. J. Pediatr. 113 (1988) 751-757
57. Graziano J.H., Lolacono N.J., Moulton T., Mitchell M.E., Slavkovich V., and Zarate C. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. J. Pediatr. 120 (1992) 133-139
58. Hastings L., Cooper G.P., Bornschein R.L., and Michaelson I.A. Behavioral effects of low level neonatal lead exposure. Pharmacol. Biochem. Behav. 7 (1977) 37-42
59. Hilson J.A., and Strupp B.J. Analyses of response patterns clarify lead effects in olfactory reversal and extradimensional shift tasks: assessment of inhibitory control, associative ability, and memory. Behav. Neurosci. 111 (1997) 532-542
60. Howell D.C. Fundamental Statistics for the Behavioral Sciences. 2nd ed. (1989), PWS-KENT, Boston
61. Huseman C.A., Varma M.M., and Angle C.R. Neuroendocrine effects of toxic and low blood lead levels in children. Pediatrics 90 (1992) 186-189
62. Jacobs D.E., Clickner R.P., Zhou J.Y., Viet S.M., Marker D.A., Rogers J.W., Zeldin D.C., Broene P., and Friedman W. The prevalence of lead-based paint hazards in U.S. housing. Environ. Health Perspect. 110 (2002) A599-A606
63. Jones M.M., Basinger M.A., Gale G.R., Atkins L.M., Smith A.B., and Stone A. Effect of chelate treatments on kidney, bone and brain lead levels of lead-intoxicated mice. Toxicology 89 (1994) 91-100
64. Koller K., Brown T., Spurgeon A., and Levy L. Recent developments in low-level lead exposure and intellectual impairment in children. Environ. Health Perspect. 112 (2004) 987-994
65. Laming D. Choice reaction performance following an error. Acta Psychol. 43 (1979) 199-224
66. Lanphear B.P., Hornung R., Khoury J., Yolton K., Baghurst P., Bellinger D.C., Canfield R.L., Dietrich K.N., Bornschein R., Greene T., Rothenberg S.J., Needleman H.L., Schnaas L., Wasserman G., Graziano J., and Roberts R. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ. Health Perspect. 113 (2005) 894-899
67. Lasky R.E., and Laughlin N.K. Exploring a partially enclosed space by lead-exposed female rhesus monkeys. Neurotoxicol. Teratol. 23 (2001) 177-183
68. Laughlin N. Efficacy of succimer for reducing adverse cognitive effects in a non-human primate model of childhood exposure. Toxicol. Sci. (Supplement) (2001)
69. E.L. Liebelt, M.W. Shannon, Oral chelators for childhood lead poisoning, Pediatr. Ann. 23 (1994) 616-619, 623-616.
70. Lilienthal H., Winneke G., Brockhaus A., and Molik B. Pre- and postnatal lead-exposure in monkeys: effects on activity and learning set formation. Neurobehav. Toxicol. Teratol. 8 (1986) 265-272
71. Luu P., Collins P., and Tucker D.M. Mood, personality, and self-monitoring: negative affect and emotionality in relation to frontal lobe mechanisms of error monitoring. J. Exp. Psychol. Gen. 129 (2000) 43-60
72. Marx M.H. Increased probability of error repetition as a function of number of successive prior repetitions. Percept. Mot. Skills 32 (1971) 544-546
73. Mendelsohn A.L., Dreyer B.P., Fierman A.H., Rosen C.M., Legano L.A., Kruger H.A., Lim S.W., and Courtlandt C.D. Low-level lead exposure and behavior in early childhood. Pediatrics 101 (1998) E10
74. Meyer P.A., Pivetz T., Dignam T.A., Homa D.M., Schoonover J., and Brody D. Surveillance for elevated blood lead levels among children-United States, 1997-2001. MMWR Surveill. Summ. 52 (2003) 1-21
75. Moreira E.G., Vassilieff I., and Vassilieff V.S. Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol. Teratol. 23 (2001) 489-495
76. Morgan R.E., Levitsky D.A., and Strupp B.J. Effects of chronic lead exposure on learning and reaction time in a visual discrimination task. Neurotoxicol. Teratol. 22 (2000) 337-345
77. Morgan R.E., Garavan H., Smith E.G., Driscoll L.L., Levitsky D.A., and Strupp B.J. Early lead exposure produces lasting changes in sustained attention, response initiation, and reactivity to errors. Neurotoxicol. Teratol. 23 (2001) 519-531
78. Munoz C., Garbe K., Lilienthal H., and Winneke G. Significance of hippocampal dysfunction in low level lead exposure of rats. Neurotoxicol. Teratol. 10 (1988) 245-253
79. Needleman H.L., and Leviton A. Lead and neurobehavioural deficit in children. Lancet 2 (1979) 104
80. Needleman H.L., Riess J.A., Tobin M.J., Biesecker G.E., and Greenhouse J.B. Bone lead levels and delinquent behavior. JAMA 275 (1996) 363-369
81. NRC. Environmental Neurotoxicology/Committee on Neurotoxicology and Models for Assessing Risk, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council (1992), National Academy Press, Washington, DC 154 pp.
82. Overmann S.R. Behavioral effects of asymptomatic lead exposure during neonatal development in rats. Toxicol. Appl. Pharmacol. 41 (1977) 459-471
83. Papini M.R., and Dudley R.T. Consequences of surprising reward omissions. Rev. Gen. Psychology 1 (1997) 175-197
84. Pappas J.B., Nuttall K.L., Ahlquist J.T., Allen E.M., and Banner Jr. W. Oral dimercaptosuccinic acid and ongoing exposure to lead: effects on heme synthesis and lead distribution in a rat model. Toxicol. Appl. Pharmacol. 133 (1995) 121-129
85. Rabbitt P., and Rodgers B. What does a man do after he makes an error? An analysis of response programming. Q. J. Exp. Psychol. 29 (1977) 727-743
86. Reiter L.W., Anderson G.E., Laskey J.W., and Cahill D.F. Developmental and behavioral changes in the rat during chronic exposure to lead. Environ. Health Perspect. 12 (1975) 119-123
87. Reith D.M., O'Regan P., Bailey C., and Acworth J. Serious lead poisoning in childhood: still a problem after a century. J. Paediatr. Child Health 39 (2003) 623-626
88. Rice D.C. Schedule-controlled behavior in infant and juvenile monkeys exposed to lead from birth. Neurotoxicology 9 (1988) 75-87
89. Rice D.C. Behavioral effects of lead in monkeys tested during infancy and adulthood. Neurotoxicol. Teratol. 14 (1992) 235-245
90. Rice D., and Barone Jr. S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 Suppl. 3 (2000) 511-533
91. Robertson I.H., Manly T., Andrade J., Baddeley B.T., and Yiend J. 'Oops!': performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 35 (1997) 747-758
92. Rogan W.J., Dietrich K.N., Ware J.H., Dockery D.W., Salganik M., Radcliffe J., Jones R.L., Ragan N.B., Chisolm Jr. J.J., and Rhoads G.G. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N. Engl. J. Med. 344 (2001) 1421-1426
93. Ronis M.J., Badger T.M., Shema S.J., Roberson P.K., Templer L., Ringer D., and Thomas P.E. Endocrine mechanisms underlying the growth effects of developmental lead exposure in the rat. J. Toxicol. Environ. Health, Part A 54 (1998) 101-120
94. Rosen J.F. Adverse health effects of lead at low exposure levels: trends in the management of childhood lead poisoning. Toxicology 97 (1995) 11-17
95. Rushworth M.F., Hadland K.A., Gaffan D., and Passingham R.E. The effect of cingulate cortex lesions on task switching and working memory. J. Cogn. Neurosci. 15 (2003) 338-353
96. Shukla R., Dietrich K.N., Bornschein R.L., Berger O., and Hammond P.B. Lead exposure and growth in the early preschool child: a follow-up report from the Cincinnati Lead Study. Pediatrics 88 (1991) 886-892
97. Singh P.K., Jones M.M., Xu Z., Gale G.R., Smith A.B., and Atkins L.M. Mobilization of lead by esters of meso-2,3-dimercaptosuccinic acid. J. Toxicol. Environ. Health 27 (1989) 423-434
98. Smith G.A., and Brewer N. Slowness and age: speed-accuracy mechanisms. Psychol. Aging 10 (1995) 238-247
99. Smith D.R., and Flegal A.R. Stable isotopic tracers of lead mobilized by DMSA chelation in low lead-exposed rats. Toxicol. Appl. Pharmacol. 116 (1992) 85-91
100. Smith D., Bayer L., and Strupp B.J. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model. Environ. Res. 78 (1998) 168-176
101. Smith D.R., Woolard D., Luck M.L., and Laughlin N.K. Succimer and the reduction of tissue lead in juvenile monkeys. Toxicol. Appl. Pharmacol. 166 (2000) 230-240
102. Stangle D.E., Strawderman M.S., Smith D., Kuypers M., and Strupp B.J. Reductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposure. Environ. Health Perspect. 112 (2004) 302-308
103. Stangle D.E., Smith D.R., Beaudin S.A., Strawderman M.S., Levitsky D.A., and Strupp B.J. Succimer chelation improves learning, attention and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure. Environ. Health Perspect. (2006) doi:10.1289/ehp.9263, available via http://dx.doi.org/ (Online 30 October 2006)
104. Stewart P.W., Blaine C., Cohen M., Burright R.G., and Donovick P.J. Acute and longer term effects of meso-2,3 dimercaptosuccinic acid (DMSA) on the behavior of lead-exposed and control mice. Physiol. Behav. 59 (1996) 849-855
105. B.J. Strupp, personal data (1993).
106. Strupp B.J., and Beaudin S.A. Assessing the neurobehavioral effects of early toxicant exposure: a perspective from animal research. In: Bellinger D. (Ed). Human Developmental Neurotoxicology (2006), Taylor and Francis Group, New York
107. Thomson G.O., Raab G.M., Hepburn W.S., Hunter R., Fulton M., and Laxen D.P. Blood-lead levels and children's behaviour-results from the Edinburgh Lead Study. J. Child Psychol. Psychiatry 30 (1989) 515-528
108. TLC, and Treatment of Lead-Exposed Children (TLC) Trial Group. Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dl. Pediatr. Res. 48 (2000) 593-599
109. Virgolini M.B., and Fulginiti A.S. Exposicion perinatal a bajas dosis de plomo en ratas: respuestas conductuales a etanol. X Congreso Argentino de Toxicologia, XVI Jornadas Interdisciplinarias de Toxicologia (1996)
110. Virgolini M.B., Cancela L.M., and Fulginiti S. Behavioral responses to ethanol in rats perinatally exposed to low lead levels. Neurotoxicol. Teratol. 21 (1999) 551-557
111. Wasserman G.A., Staghezza-Jaramillo B., Shrout P., Popovac D., and Graziano J. The effect of lead exposure on behavior problems in preschool children. Am. J. Public Health 88 (1998) 481-486
112. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1 (1945) 80-83
113. Winneke G., Brockhaus A., and Baltissen R. Neurobehavioral and systemic effects of longterm blood lead-elevation in rats: I. Discrimination learning and open field-behavior. Arch. Toxicol. 37 (1977) 247-263
114. Winneke G., Lilienthal H., and Werner W. Task dependent neurobehavioral effects of lead in rats. Arch. Toxicol. Suppl. 5 (1982) 84-93
115. Wolfinger R., and O'Connell M. Generalized linear mixed models: a pseudo-likelihood approach. J. Stat. Comput. Simul. 48 (1993) 233-244
116. Woolard D.L., Koscica T., Rhodes D.L., Cui H.L., Pastore R.A., Jensen J.O., Jensen J.L., Loerop W.R., Jacobsen R.H., Mittleman D., and Nuss M.C. Millimeter wave-induced vibrational modes in DNA as a possible alternative to animal tests to probe for carcinogenic mutations. J. Appl. Toxicol. 17 (1997) 243-246
117. Xu Z.F., and Jones M.M. Comparative mobilization of lead by chelating agents. Toxicology 53 (1988) 277-288
118. Yu S.Y., Mizinga K.M., Nonavinakere V.K., and Soliman K.F. Decreased endurance to cold water swimming and delayed sexual maturity in the rat following neonatal lead exposure. Toxicol. Lett. 85 (1996) 135-141
119. Zeger S.L., Liang K.Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988) 1049-1060